INO-3107
RRP-001
Phase 2 small_molecule completed
Quick answer
INO-3107 for Respiratory Papillomatosis is a Phase 2 program (small_molecule) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Respiratory Papillomatosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed